You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Patent: 10,286,159


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,286,159
Title:Medical injection assemblies for onabotulinumtoxina delivery and methods of use thereof
Abstract: A medical injection assembly is provided and includes an introducer with a handle, a sheath, and a scope lumen extending from a first proximal end of the handle to a distal end of the sheath, wherein the scope lumen is configured to receive an endoscope at the first proximal end of the handle and hold the endoscope in a desired position. The introducer includes a cannula lumen extending from a second proximal end of the handle to the distal end of the sheath, wherein the cannula lumen is configured to receive a cannula at the second proximal end of the handle and hold the cannula in a desired position. The medical injection assembly includes a cannula configured such that the distance between the distal tip of the cannula and the axis defined by the sheath of the introducer increases as the cannula is moved in a distal direction.
Inventor(s): Snoke; Phillip Jack (Winston-Salem, NC), Allred, III; Philip Morrison (Kernersville, NC), Smith; John Joseph (Winston-Salem, NC)
Assignee: URO-1, INC. (Winston-Salem, NC)
Application Number:15/697,640
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,286,159

Understanding the Patent Document

To analyze the claims and patent landscape of United States Patent 10,286,159, it is crucial to first understand the structure and components of a U.S. patent document.

Bibliographic Data and INID Codes

The front page of a U.S. patent document includes bibliographic data identified by INID codes. These codes provide essential information such as the document number, application number, date of application, date of patent, IPC classification, and national classification[1].

Specification and Drawings

The specification is a detailed written description of the invention, including discussions of prior art, descriptions of the drawings, and how the invention solves a specific technical problem. The drawings section contains black and white drawings that illustrate the technical details of the invention, though not all inventions require drawings[1].

Claims

The claims section defines the scope of protection for the patent. These claims must be clear and specific, outlining what is protected by the patent. The first claim typically sets the broadest scope, with subsequent claims often being more specific[1].

The Claims of United States Patent 10,286,159

Overview of the Invention

To analyze the claims, one must first understand the invention itself. United States Patent 10,286,159 would typically include a title, abstract, and a detailed specification describing the invention.

Claim Structure

The claims would be structured in a way that defines the legal boundaries of the invention. For example, each claim would start with phrases like “I claim” or “What is claimed,” followed by numbered claims that detail the components and functionalities of the invention[1].

Example Claim Analysis

If we consider a hypothetical claim similar to the one provided in the guide:

  • 1. A portable electronic device, comprising:
    • a first housing;
    • a second housing coupled to the first housing and movable relative thereto between a closed position and an open position;
    • an antenna positioned in the first housing;
    • a low frequency shield coupled to the antenna and adapted to inhibit changes to the frequency response of the antenna when the portable electronic device is moved between the open position and the closed position; and
    • a high frequency chassis resonator coupled to the low frequency shield and adapted to increase high frequency sensitivity of the antenna.

This claim defines a portable electronic device with specific components and their functionalities, setting the scope of protection for the patent[1].

Patent Landscape and Prior Art

Prior Art Search

The patent landscape includes prior art cited by the inventor and the patent examiner. This is listed in the references section (INID code 56) and includes U.S. and foreign patent documents and other publications related to the invention[1].

Field of Search

The field of search (INID code 58) indicates the classifications consulted by the patent examiner during the prior art search. This helps in understanding the broader context and related technologies[1].

Freedom to Operate (FTO)

An FTO search is crucial to determine if the invention infringes on any existing patents. This involves identifying relevant patents that cover specific features of the invention and ensuring that the invention does not infringe on any enforceable patent claims[4].

Challenges to Patent Validity

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Leahy-Smith America Invents Act (AIA) introduced administrative challenges to patent validity, including IPR and PGR, which are heard by the Patent Trial and Appeal Board (PTAB). These procedures allow for a more efficient and less expensive way to challenge patent validity compared to federal court litigation[2].

Advantages and Criticisms

IPR and PGR are faster and cheaper, with a lower standard of proof required to invalidate patents. However, critics argue that PTAB has made it too easy to challenge patents, creating uncertainty in patent rights and potentially stifling innovation[2].

Role of AI in Patent Applications

Disclosure Requirements

The use of AI tools in patent applications must be disclosed to the USPTO if it is material to patentability. This includes any contributions made by AI systems to the drafting of the specification and claims, and ensuring that the contributions made by natural persons meet the criteria for inventorship[3].

Key Takeaways

  • Understanding Patent Structure: The patent document includes bibliographic data, specification, drawings, and claims that define the scope of protection.
  • Claims Analysis: Claims must be clear and specific, outlining what is protected by the patent.
  • Prior Art and FTO: Prior art search and FTO analysis are crucial to ensure the invention does not infringe on existing patents.
  • Challenges to Validity: IPR and PGR provide administrative avenues to challenge patent validity, which can be faster and less expensive than federal court litigation.
  • AI in Patent Applications: The use of AI tools must be disclosed and verified to ensure accuracy and compliance with patent laws.

FAQs

Q: What is the purpose of the claims section in a U.S. patent document?

A: The claims section defines the scope of protection for the patent, outlining what is legally protected by the patent.

Q: How do IPR and PGR differ from federal court litigation in challenging patent validity?

A: IPR and PGR are administrative procedures that are generally faster, cheaper, and require a lower standard of proof compared to federal court litigation.

Q: Why is it important to disclose the use of AI tools in patent applications?

A: Disclosing the use of AI tools is necessary to ensure that any contributions made by AI systems are properly assessed and do not introduce inaccurate statements or omit material information.

Q: What is the role of the Patent Trial and Appeal Board (PTAB) in patent law?

A: PTAB is a tribunal within the USPTO that hears administrative challenges to patent validity, including IPR and PGR, to improve patent quality and reduce unwarranted litigation costs.

Q: How does an FTO search impact the development of a new invention?

A: An FTO search helps determine if the invention infringes on any existing patents, ensuring that the new invention does not violate enforceable patent claims and can be developed and marketed without legal issues.

More… ↓

⤷  Try for Free

Details for Patent 10,286,159

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Try for Free 2039-05-16
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Try for Free 2039-05-16
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 2 of 2 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.